Clinical Trial Update: Use of A Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update for MITI 001, a complex gut bacterial consortium, aimed at treating irritable bowel syndrome with diarrhea; the study is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• MITI 001

Snippet

Sponsor: Stanford University | Conditions: IBS (Irritable Bowel Syndrome), Diarrhea | EARLY_Phase 1 | Status: NOT_YET_RECRUITING